NUCLITHERA AS
Developing targeted alpha and beta emitters for metastatic cancer treatment.
Oversigt
- 9
- Medarbejdere
- 3.2mio NOK
- Omsætning
- 2023
- Grundlagt
Nøglebeslutningstagere
Øyvind S. Bruland
CMO
Ada Repetto-Llamazares
CSO
Morten Lande
Board Member
Roy Hartvig Larsen
CTO
+1 flere kontakter i Funnelfeedr
Beskrivelse
NucliThera a.s is a specialized research and development company focused on innovative cancer therapies. The core mission involves creating targeted short-range radionuclides, specifically alpha- and beta-emitters, for treating metastatic cancers. These high-energy nuclides are chemically linked to...
Tags
Nøgleord
Teknologistak
Virksomhedsoplysninger
- Branche
- Ukendt
- Juridisk form
- Aksjeselskap
- Momsnummer
- Ukendt
Beslutningstagere
5 kontakter i FunnelfeedrØyvind S. Bruland
CMO
Ada Repetto-Llamazares
CSO
Morten Lande
Board Member
Roy Hartvig Larsen
CTO
Ludvik Sandnes
CEO, CFO
Lignende virksomheder
20 lignende virksomheder i Funnelfeedr
ONCOINVENT SOLUTIONS AS
44 medarbejdereNorwegian biotech transforming cancer care via direct alpha therapy.
Isofol Medical AB (publ)
10–19 medarbejdereDeveloping next-generation folate drug to improve cancer treatment efficacy.
SACRA Therapeutics AB
0 medarbejdereSACRA pioneers novel RNA-targeting therapies for incurable cancers.
ARTBIO AS
19 medarbejdereDeveloping novel alpha radioligand therapies to redefine cancer care.
BioGaia Pharma AB
0 medarbejdereDeveloping and out-licensing novel biotherapeutic platforms from microbiome research.
Udforsk mere
Spørgsmål om NUCLITHERA AS
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo